Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

NCT: NCT05739162 · ACTIVE_NOT_RECRUITING

NCT IDNCT05739162
StatusACTIVE_NOT_RECRUITING
Start Date2023-09-20
Completion2027-01
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research is to gather information on the safety and effectiveness of Endoscopic Sleeve Gastroplasty (ESG) for weight loss in a population of obese UC patients undergoing colectomy with eventual IPAA.

Frequently Asked Questions

What is A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis?

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis is a clinical trial registered under NCT05739162. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05739162?

The current status of NCT05739162 (A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis) is: ACTIVE_NOT_RECRUITING.

When did A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis start?

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis started on 2023-09-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.